GIOVANNONI, GIULIO
 Distribuzione geografica
Continente #
EU - Europa 140
NA - Nord America 80
AS - Asia 62
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 9
AF - Africa 2
Totale 303
Nazione #
RU - Federazione Russa 75
US - Stati Uniti d'America 70
IT - Italia 38
SG - Singapore 21
CN - Cina 17
BR - Brasile 8
GB - Regno Unito 7
VN - Vietnam 7
FR - Francia 6
HK - Hong Kong 5
MX - Messico 5
NL - Olanda 4
IN - India 3
BD - Bangladesh 2
BE - Belgio 2
CA - Canada 2
FI - Finlandia 2
SE - Svezia 2
TH - Thailandia 2
ZA - Sudafrica 2
AR - Argentina 1
AT - Austria 1
CR - Costa Rica 1
DE - Germania 1
GD - Grenada 1
GT - Guatemala 1
HU - Ungheria 1
ID - Indonesia 1
JP - Giappone 1
KR - Corea 1
PK - Pakistan 1
PL - Polonia 1
TR - Turchia 1
Totale 293
Città #
Ashburn 15
Moscow 14
Singapore 10
Milan 8
Los Angeles 6
San Jose 6
Council Bluffs 5
Hong Kong 5
New York 5
Manchester 4
Rho 4
Seriate 4
Bologna 3
Dallas 3
Ho Chi Minh City 3
Rome 3
Santa Clara 3
Bangkok 2
Beijing 2
Brussels 2
Hanoi 2
Lauterbourg 2
Mexico City 2
Orem 2
Porcia 2
Querétaro 2
Shanghai 2
Siano 2
Stockholm 2
Turin 2
Turku 2
Americana 1
Amsterdam 1
Assis 1
Bari 1
Barnet 1
Boardman 1
Bossier City 1
Brescia 1
Budapest 1
Buffalo 1
Busto Arsizio 1
Cape Town 1
Cartago 1
Catania 1
Chennai 1
Chicago 1
Espelkamp 1
Francisco Sá 1
Hefei 1
Houston 1
Hà Tĩnh 1
Indianapolis 1
Indpls 1
Islamabad 1
Izmir 1
Jatai 1
Jeju City 1
Johannesburg 1
Juneau 1
London 1
Maceió 1
Maringá 1
Merrick 1
Mesa 1
Milton Keynes 1
Mumbai 1
Newark 1
Pekanbaru 1
Rio de Janeiro 1
Rubiera 1
Saint George's 1
San Mateo 1
San Salvador de Jujuy 1
Sarnia 1
Serafina Corrêa 1
Thái Nguyên 1
Tokyo 1
Toronto 1
Warsaw 1
Totale 178
Nome #
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 173
A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking 72
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength 53
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study 5
Totale 303
Categoria #
all - tutte 1.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202527 0 0 0 0 0 0 0 0 0 0 16 11
2025/2026240 6 11 12 29 28 14 9 27 71 23 4 6
2026/202736 24 12 0 0 0 0 0 0 0 0 0 0
Totale 303